Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02437071Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer PatientsTreatment
NCT02981524Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal CancerTreatment
NCT02260440A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal CancerTreatment